GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (LTS:0FIW) » Definitions » Price-to-Free-Cash-Flow

Embla Medical hf (LTS:0FIW) Price-to-Free-Cash-Flow : 62.17 (As of May. 03, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Embla Medical hf Price-to-Free-Cash-Flow?

As of today (2024-05-03), Embla Medical hf's share price is kr47.00. Embla Medical hf's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.76. Hence, Embla Medical hf's Price-to-Free-Cash-Flow Ratio for today is 62.17.

The historical rank and industry rank for Embla Medical hf's Price-to-Free-Cash-Flow or its related term are showing as below:

LTS:0FIW' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 14.19   Med: 39.41   Max: 71.21
Current: 38.62

During the past 13 years, Embla Medical hf's highest Price-to-Free-Cash-Flow Ratio was 71.21. The lowest was 14.19. And the median was 39.41.

LTS:0FIW's Price-to-Free-Cash-Flow is ranked worse than
59.76% of 333 companies
in the Medical Devices & Instruments industry
Industry Median: 32.03 vs LTS:0FIW: 38.62

Embla Medical hf's Free Cash Flow per Share for the three months ended in Mar. 2024 was kr-0.12. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was kr0.76.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Embla Medical hf was 63.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -5.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 0.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 2.50% per year.

During the past 13 years, Embla Medical hf's highest 3-Year average Free Cash Flow per Share Growth Rate was 115.10% per year. The lowest was -16.50% per year. And the median was 4.00% per year.


Embla Medical hf Price-to-Free-Cash-Flow Historical Data

The historical data trend for Embla Medical hf's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Price-to-Free-Cash-Flow Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.09 49.09 36.81 57.35 32.45

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.10 52.79 41.67 32.45 44.31

Competitive Comparison of Embla Medical hf's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Embla Medical hf's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Price-to-Free-Cash-Flow falls into.



Embla Medical hf Price-to-Free-Cash-Flow Calculation

Embla Medical hf's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=47.00/0.756
=62.17

Embla Medical hf's Share Price of today is kr47.00.
Embla Medical hf's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.76.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Embla Medical hf  (LTS:0FIW) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Embla Medical hf Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (LTS:0FIW) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (LTS:0FIW) Headlines

No Headlines